GIP and type 2 diabetes mellitus: In a similar way, the secretion of GIP and GLP-1 is greater at higher doses, which does not affect peak GIP and GLP-1 concentrations, but leads to a prolonged elevation in GIP and GLP-1 plasma concentrations after oral glucose administration both in healthy individuals and in those with type 2 diabetes.